SBH
Segall Bryant & Hamill Portfolio holdings
AUM
$7.12B
1-Year Return
18.91%
This Quarter Return
+10.88%
1 Year Return
+18.91%
3 Year Return
+73.09%
5 Year Return
+143.62%
10 Year Return
+348.23%
AUM
$7.12B
AUM Growth
+$596M
(+9.1%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$34.2M |
| 2 |
Marvell Technology
MRVL
|
$19.2M |
| 3 |
Arista Networks
ANET
|
$18.7M |
| 4 |
Quanta Services
PWR
|
$18.2M |
| 5 |
Flowserve
FLS
|
$18.1M |
Top Sells
| 1 |
REV Group
REVG
|
$59.8M |
| 2 |
UnitedHealth
UNH
|
$43.8M |
| 3 |
AZEK
The AZEK Co
AZEK
|
$25.3M |
| 4 |
McKesson
MCK
|
$21.9M |
| 5 |
Foot Locker
FL
|
$18.2M |
Sector Composition
| 1 | Technology | 20.65% |
| 2 | Industrials | 18.36% |
| 3 | Financials | 15.32% |
| 4 | Healthcare | 12.69% |
| 5 | Consumer Discretionary | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Eaton
ETN
$136B
| $7.1M | 0.1% |
19,900
-85
| -0.4% | -$30.3K |
|
277
AbbVie
ABBV
$375B
| $7.03M | 0.1% |
37,862
| – | – |
|
278
Denali Therapeutics
DNLI
$2.26B
| $7M | 0.1% |
500,559
+219,420
| +78% | +$3.07M |
|
279
Deckers Outdoor
DECK
$17.9B
| $6.98M | 0.1% |
+67,761
| New | +$6.98M |
|
280
LeMaitre Vascular
LMAT
$2.21B
| $6.88M | 0.1% |
82,795
+6,335
| +8% | +$526K |
|
281
Starbucks
SBUX
$97.1B
| $6.82M | 0.1% |
74,453
-17,672
| -19% | -$1.62M |
|
282
Loar Holdings
LOAR
$7.16B
| $6.66M | 0.09% |
+77,261
| New | +$6.66M |
|
283
Protagonist Therapeutics
PTGX
$3.77B
| $6.64M | 0.09% |
+120,159
| New | +$6.64M |
|
284
Analog Devices
ADI
$122B
| $6.58M | 0.09% |
+27,658
| New | +$6.58M |
|
285
JPMorgan BetaBuilders Canada ETF
BBCA
$8.72B
| $6.56M | 0.09% |
81,304
-2,369
| -3% | -$191K |
|
286
Graphic Packaging
GPK
$6.38B
| $6.52M | 0.09% |
309,365
+12,042
| +4% | +$254K |
|
287
Civitas Resources
CIVI
$3.19B
| $6.41M | 0.09% |
232,960
-103,016
| -31% | -$2.84M |
|
288
Jacobs Solutions
J
$17.4B
| $6.4M | 0.09% |
48,702
-65,282
| -57% | -$8.58M |
|
289
IBM
IBM
$232B
| $6.39M | 0.09% |
21,680
-2,057
| -9% | -$606K |
|
290
Allegiant Air
ALGT
$1.18B
| $6.28M | 0.09% |
114,207
-1,160
| -1% | -$63.7K |
|
291
iShares Russell 2000 ETF
IWM
$67.8B
| $5.93M | 0.08% |
27,503
-13,700
| -33% | -$2.96M |
|
292
InterDigital
IDCC
$7.43B
| $5.93M | 0.08% |
26,451
-1,817
| -6% | -$407K |
|
293
GXO Logistics
GXO
$6.02B
| $5.89M | 0.08% |
+121,042
| New | +$5.89M |
|
294
Revolve Group
RVLV
$1.7B
| $5.89M | 0.08% |
293,725
+49,618
| +20% | +$995K |
|
295
Vaxcyte
PCVX
$4.29B
| $5.86M | 0.08% |
180,239
+30,477
| +20% | +$991K |
|
296
Vericel Corp
VCEL
$1.72B
| $5.75M | 0.08% |
135,095
+60,185
| +80% | +$2.56M |
|
297
Arthur J. Gallagher & Co
AJG
$76.7B
| $5.73M | 0.08% |
17,895
-2,815
| -14% | -$901K |
|
298
Regal Rexnord
RRX
$9.66B
| $5.71M | 0.08% |
39,396
+1,171
| +3% | +$170K |
|
299
Cooper Companies
COO
$13.5B
| $5.7M | 0.08% |
80,038
-3,273
| -4% | -$233K |
|
300
Neurocrine Biosciences
NBIX
$14.3B
| $5.67M | 0.08% |
45,091
-8,012
| -15% | -$1.01M |
|